News | March 20, 2024
AstraZeneca buys biopharmaceutical company Fusion
To accelerate the development of next-generation radioconjugates to treat cancer
To accelerate the development of next-generation radioconjugates to treat cancer
Lonza plans to invest approximately CHF 500 million to upgrade the facility
Acquisition to further expand the Alexion, AstraZeneca Rare Disease pipeline beyond complement inhibition
Grand opening of the joint venture between Evonik China and Shandong Vland Biotech in Qingdao, China
Chlorpromazine Hydrochloride Injection is used to treat certain mental/mood disorders
Completes acquisition of 75% of share capital from Glenmark Pharmaceuticals
Venus Remedies' manufacturing unit, located in Baddi, Himachal Pradesh, has been recommended for supplying cephalosporin dry powder to UNICEF
India is contributing 13% to the global asthma burden and a disproportionate 43% of the global asthma deaths.
AbCellera will receive an upfront payment and is eligible to receive additional milestone payments
These approvals mark significant progress for Venus Remedies in expanding its market presence
Subscribe To Our Newsletter & Stay Updated
